No profile data available.
eXoZymes, Inc. (EXOZ) is a non-energy raw materials company in the additional chemical compound production industry, based in Monrovia, United States, with about 32 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$9.16 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $48.85 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc.
eXoZymes reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$48.85 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional chemical compound production) include Codexis, Inc. (CDXS), Arq, Inc. (ARQ), Flexible Solutions International, Inc. (FSI), Nocopi Technologies, Inc. (NNUP).